Glaucoma clinical trials

Explore recruiting glaucoma clinical trials.

Recruiting glaucoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glaucoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, parallel group clinical trial to evaluate the efficacy and safety of PRGF eye drops as a treatment for dry eye disease in patients with glaucoma

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Evaluation of the regenerative efficacy of Endoret® (PRGF-Plasm Rich in Growth Factors) on the ocular surface of glaucoma patients treated chronically with ocular hypotensive drugs, Evaluación de la eficacia regenerativa de Endoret® (PRGF-Plasma Rico en Factores de Crecimiento) en la superficie ocular de pacientes glaucomatosos tratados de forma crónica con fármacos hipotensores oculares

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Additive Benefits of Semaglutide for open-AngLe glaucoma – an Opportunity for Neuroprotection (ABSALON)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Selective laser trabeculoplasty versus eye drops for first line treatment of exfoliation ocular hypertension or glaucoma: a randomised clinical trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A phase III multicenter, double-blind, randomized, placebo-controlled, parallel-group trial of the efficacy of citicoline eyedrops 2% on visual field preservation in patients with open angle glaucoma

Hungary, Belgium, France, Spain, Greece, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma

Belgium, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Glaucoma trials by city

Glaucoma in Toronto Glaucoma in Vancouver Glaucoma in Montreal Glaucoma in Calgary Glaucoma in Edmonton Glaucoma in Ottawa Glaucoma in Winnipeg Glaucoma in Quebec City Glaucoma in Hamilton Glaucoma in Kitchener Glaucoma in London Glaucoma in Halifax Glaucoma in New York Glaucoma in Los Angeles Glaucoma in Chicago Glaucoma in Houston

Other conditions

Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Glioblastoma Head and neck cancer Cervical cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Dry eye disease HIV Hepatitis B Hepatitis C COVID-19 Influenza RSV Sickle cell disease Anemia Hemophilia Thalassemia Chronic pain